Intrinsic Value of S&P & Nasdaq Contact Us

Akanda Corp. AKAN NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • GB • USD

SharesGrow Score
34/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Akanda Corp. (AKAN) has a negative trailing P/E of -0.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -807.72%.

Criteria proven by this page:

  • VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -0.1); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -807.72%).
  • Trailing Earnings Yield -807.72% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 32/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
34/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
25/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
29/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — AKAN

Valuation Multiples
P/E (TTM)-0.1
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.08
P/S Ratio0.28
EV/EBITDA0.8
Per Share Data
EPS (TTM)$-5.53
Book Value / Share$8.20
Revenue / Share$0.89
FCF / Share$-6.25
Yields & Fair Value
Earnings Yield-807.72%
Dividend Yield0.00%

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 -4,821.1 0.00 0.00 0.00 -
2020 -3,957.4 -70.71 -1,809.32 4,415,316.20 -
2021 -1,119.7 -5.25 -4,135.68 219,748.06 -
2022 -13.3 0.13 5.76 59.10 -
2023 -8.5 0.01 -71.41 126.59 -
2024 -6.1 0.07 5.85 29.89 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-26.14 $0.00 $-1.89M -
2020 $-40.77 $2.06K $-2.95M -142869.6%
2021 $-127.66 $41.43K $-9.22M -22263.8%
2022 $4.59 $2.62M $397.05K 15.2%
2023 $-7.16 $2.16M $-32.28M -1494.2%
2024 $-3.93 $836.66K $-4.1M -489.6%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message